Computer and textbooks

Back to For Health Professionals>>

View a comprehensive list of career growth and educational aids to guide and inform you, whether you are exploring the field of clinical laboratory medicine or looking to advance your career.


Educate Your Patients on Biotin Test Interference

In late November 2017, the Food and Drug Administration (FDA) published a safety alert to make the public and healthcare practitioners more aware that biotin can "significantly interfere with certain lab tests and cause incorrect test results…" According to the safety alert, there has been "an increase in the number of reported adverse events, including one death, related to biotin interference with lab tests." The one death occurred when a patient taking high doses of biotin had falsely low troponin results from a troponin test known to have interference from biotin.

Related Articles 

From AACC: Preventing a Widespread Beauty Fad From Interfering With Medical Tests 

Related Educational Offerings 

Biotin and Laboratory Testing: Recognizing Interferences and Preventing Misdiagnosis (FREE) 

On this Site

Tests: B Vitamins | Feature Articles:  Test Preparation: Your Role | In the News: FDA Warns that Biotin May Affect Some Lab Test Results

Biotin Q&A - Sponsored by Abbott Logo

 Sponsored Content Logo

What are some common tests affected by biotin interference?

Biotin can affect a wide variety of laboratory tests. Examples include tests for:

  • Troponin
  • Thyroid hormone tests, such as thyroid stimulating hormone (TSH), thyroxine (T4) and triiodothyronine (T3) tests
  • Other hormones, such as parathyroid hormone (PTH), cortisol, follicle -stimulating hormone (FSH) and luteinizing hormone (LH)
  • Vitamin D levels

Some laboratory platforms use methods that do not experience interference from biotin, even for the examples listed above. Tests that employ methods free from biotin interference can sometimes be used for re-testing samples from patients in whom biotin interference is suspected, similar to what is seen in the video, Biotin: Friend and Foe, found below in the Related Video section. Abbott Laboratories is one example of a diagnostic company that manufactures immunoassays that are not susceptible to biotin interference. Alternatively, re-testing may be done at a later time, after the patient has refrained from taking biotin.

How can a Health Care Practitioner prepare a patient for tests?

The FDA advises healthcare  practitioners to ask their patients if they are taking any biotin supplements and inform the testing laboratory if interference from biotin is a possibility. They should also consider biotin interference as a potential reason for lab results not matching with a patient's signs and symptoms and/or suspected health condition.

Get more answers to common biotin interference related questions

AACC Featured Education

Featured Podcast: Non-invasive Detection of Cocaine and Heroin Use Using Single Fingerprints (FREE) with Transcript 

Featured Upcoming Webinar: 

New! Increasing STI Screening Coverage by Focusing on the End Users: Clinicians and Patients - September 5, 1 pm - 2 pm ET*

The stigma associated with sexually transmitted infections (STIs) is one of the most significant hurdles in early detection and treatment. Barbara Van Der Pol PhD, MPH, shares her experiences from years of conducting STI research and discusses the need to provide STI services that change the current clinical models and reduce stigma through education.

View the full Library of On Demand Webinars (you will re-directed to

Check out these additional offerings:

Accordion Title
Career Advancement Resources
CDC Alerts and Resources
Alerts and Events
  • Vital Signs - Zika in Babies in US Territories, 8/1/
  • Alerts -Rising Numbers of Deaths Involving Fentanyl, 7/11
  • Vital Signs - Illnesses on the rise from Mosquito, Tick and Flea Bites, 5/2
  • Vital Signs - Unusual Antibiotic Resistance, 4/3
  • Vital Signs  - Opioid Overdoses, 3/3